Peptide Companion
Back to catalog
Peptide Companion
single
Immune
Vial: 10 mg

Thymosin Alpha-1 (10 mg Vial)

Thymosin Alpha-1 (Tα1) is a 28–amino acid peptide originally isolated from the thymus gland, recognized for its broad immunomodulatory properties. It has been investigated as an immune enhancer in chronic viral infections (hepatitis B/C, HIV/AIDS) and critical illness (sepsis, COVID-19). This educational protocol presents a once‑daily subcutaneous approach using a practical dilution for clear insulin‑syringe measurements.

Detailed protocol below.

Dosing Schedule
WeekDaily Dose (mcg)Units (per injection) (mL)
Week 1300 mcg (0.3 mg)9 units (0.09 mL)
Weeks 2–8500 mcg (0.5 mg)15 units (0.15 mL)
Supplies Needed
  • •Peptide Vials (Thymosin Alpha-1, 10 mg each):
  • •Insulin Syringes (U‑100):
  • •Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.
  • •Alcohol Swabs: One for the vial stopper + one for the injection site each day.
References

  • World Journal of Virology

    Dominari et al. (2020): Comprehensive review of Thymosin Alpha-1 mechanisms, dosing (0.8–6.4 mg SC), and clinical applications

    View source

  • Molecules (MDPI)

    Tao et al. (2023): Thymosin Alpha-1 in viral diseases—mechanisms and therapeutic applications in HBV, HCV, and HIV

    View source

  • Inflammopharmacology

    Soeroto et al. (2023): Meta-analysis of Tα1 in COVID-19; significant mortality reduction in moderate-to-critical patients

    View source

  • Annals of the New York Academy of Sciences

    Thymosin Alpha-1: biological activities, clinical applications, and pharmacokinetics review

    View source

  • Clinical Immunology

    Mechanisms of thymosin alpha-1 immunomodulation: T-cell maturation and cytokine production

    View source

  • Hospital Pharmacy

    Jordan et al. (2021): Small-volume injection accuracy; recommends ≥20% syringe capacity for precision

    View source

  • CDC

    Vaccine administration: subcutaneous route (angle/site; no aspiration required)

    View source

  • Johns Hopkins Arthritis Center

    How to give a subcutaneous injection: site selection, rotation, and technique

    View source

  • NCBI Bookshelf

    Best practices for injection: asepsis, preparation, site rotation, and administration

    View source

  • Subcutaneous Drug Injection Review (PMC)

    Pharmacologic considerations of the subcutaneous route

    View source

Educational content adapted from peptidedosages.com. Not medical advice.